A pay-for-performance programme in participating CRUSADE hospitals does not improve quality of care or outcomes for patients with acute myocardial infarction

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.530, 2007-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential of Microvascular Reperfusion with Adjunctive Pharmacological Intervention: Its Impact on Myocardial Perfusion and Functional Outcomes in Patients with Acute Myocardial Infarction

By Taniyama Y.  

Drugs, Vol. 61, Iss. 4, 2001-01 ,pp. : 437-441

Adis International

Access to resources Recommend Favorite

Practical approaches to monitoring care in acute myocardial infarction

By Bruce Diane L  

Clinical Medicine, Vol. 1, Iss. 1, 2001-01 ,pp. : 70-71

Royal College Of Physicians

Access to resources Recommend Favorite

Tilarginine does not reduce the risk of mortality for patients with acute myocardial infarction (MI) and cardiogenic shock

By  

Inpharma, Vol. 1, Iss. 1581, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

The need for pharmaceutical care in the prevention of coronary heart disease: an exploratory study in acute myocardial infarction patients

By Chinwong Surarong   Reid Fiona   McGlynn Steve   Hudson Steve   Flapan Andy  

Pharmacy World and Science, Vol. 26, Iss. 2, 2004-04 ,pp. : 96-101

Springer Publishing Company

Access to resources Recommend Favorite

Anakinra in Experimental Acute Myocardial Infarction—Does Dosage or Duration of Treatment Matter?

By Salloum Fadi   Chau Vinh   Varma Amit   Hoke Nicholas   Toldo Stefano   Biondi-Zoccai Giuseppe   Crea Filippo   Vetrovec George   Abbate Antonio  

Cardiovascular Drugs and Therapy, Vol. 23, Iss. 2, 2009-04 ,pp. : 129-135

Springer Publishing Company

Access to resources Recommend Favorite